Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)
Status:
Completed
Trial end date:
2017-02-23
Target enrollment:
Participant gender:
Summary
This study plans to learn more about a new test to look at liver function, the HepQuant-Shunt
(HQ-Shunt). The HQ-Shunt is being evaluated for safety and effectiveness as an alternative to
Hepatic Venous Pressure Gradient testing in patients with liver disease.